Selected research
Industry Research
Animal Generic Drug Industry Research Report 2026
Market perspective
The global Animal Generic Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal Generic Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal Generic Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal Generic Drug include Zoetis, Merck, Bayer Animal Health, Vetoquinol, Perrigo, Norbrook, Huvepharma, Elanco and Ceva Sante Animale, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal Generic Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Generic Drug Market by Company
Zoetis
Merck
Bayer Animal Health
Vetoquinol
Perrigo
Norbrook
Huvepharma
Elanco
Ceva Sante Animale
Boehringer Ingelheim
Bimeda
Animal Generic Drug Segment by Type
Pharmaceuticals
Medicinal Feed Additives
Biologicals
Animal Generic Drug Segment by Application
Cows
Broilers
Pigs
Others
Animal Generic Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Generic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Generic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Generic Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal Generic Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal Generic Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal Generic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceuticals
- Medicinal Feed Additives
- Biologicals
Applications
- Cows
- Broilers
- Pigs
- Others
Companies covered
- Zoetis
- Merck
- Bayer Animal Health
- Vetoquinol
- Perrigo
- Norbrook
- Huvepharma
- Elanco
- Ceva Sante Animale
- Boehringer Ingelheim
- Bimeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal Generic Drug Market Size (2021-2032)
- 2.2.2 Global Animal Generic Drug Sales (2021-2032)
- 2.2.3 Global Animal Generic Drug Market Average Price (2021-2032)
- 2.3 Animal Generic Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceuticals
- 2.3.3 Medicinal Feed Additives
- 2.3.4 Biologicals
- 2.4 Animal Generic Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cows
- 2.4.3 Broilers
- 2.4.4 Pigs
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal Generic Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal Generic Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Animal Generic Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal Generic Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal Generic Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal Generic Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal Generic Drug, Product Type & Application
- 3.8 Global Manufacturers of Animal Generic Drug, Established Date
- 3.9 Global Animal Generic Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Animal Generic Drug Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Animal Generic Drug Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Bayer Animal Health
- 4.3.1 Bayer Animal Health Company Information
- 4.3.2 Bayer Animal Health Business Overview
- 4.3.3 Bayer Animal Health Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer Animal Health Animal Generic Drug Product Portfolio
- 4.3.5 Bayer Animal Health Recent Developments
- 4.4 Vetoquinol
- 4.4.1 Vetoquinol Company Information
- 4.4.2 Vetoquinol Business Overview
- 4.4.3 Vetoquinol Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vetoquinol Animal Generic Drug Product Portfolio
- 4.4.5 Vetoquinol Recent Developments
- 4.5 Perrigo
- 4.5.1 Perrigo Company Information
- 4.5.2 Perrigo Business Overview
- 4.5.3 Perrigo Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Animal Generic Drug Product Portfolio
- 4.5.5 Perrigo Recent Developments
- 4.6 Norbrook
- 4.6.1 Norbrook Company Information
- 4.6.2 Norbrook Business Overview
- 4.6.3 Norbrook Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Norbrook Animal Generic Drug Product Portfolio
- 4.6.5 Norbrook Recent Developments
- 4.7 Huvepharma
- 4.7.1 Huvepharma Company Information
- 4.7.2 Huvepharma Business Overview
- 4.7.3 Huvepharma Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Huvepharma Animal Generic Drug Product Portfolio
- 4.7.5 Huvepharma Recent Developments
- 4.8 Elanco
- 4.8.1 Elanco Company Information
- 4.8.2 Elanco Business Overview
- 4.8.3 Elanco Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Elanco Animal Generic Drug Product Portfolio
- 4.8.5 Elanco Recent Developments
- 4.9 Ceva Sante Animale
- 4.9.1 Ceva Sante Animale Company Information
- 4.9.2 Ceva Sante Animale Business Overview
- 4.9.3 Ceva Sante Animale Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ceva Sante Animale Animal Generic Drug Product Portfolio
- 4.9.5 Ceva Sante Animale Recent Developments
- 4.10 Boehringer Ingelheim
- 4.10.1 Boehringer Ingelheim Company Information
- 4.10.2 Boehringer Ingelheim Business Overview
- 4.10.3 Boehringer Ingelheim Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Boehringer Ingelheim Animal Generic Drug Product Portfolio
- 4.10.5 Boehringer Ingelheim Recent Developments
- 4.11 Bimeda
- 4.11.1 Bimeda Company Information
- 4.11.2 Bimeda Business Overview
- 4.11.3 Bimeda Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bimeda Animal Generic Drug Product Portfolio
- 4.11.5 Bimeda Recent Developments
5 Global Animal Generic Drug Market Scenario by Region
- 5.1 Global Animal Generic Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal Generic Drug Sales by Region: 2021-2032
- 5.2.1 Global Animal Generic Drug Sales by Region: 2021-2026
- 5.2.2 Global Animal Generic Drug Sales by Region: 2027-2032
- 5.3 Global Animal Generic Drug Revenue by Region: 2021-2032
- 5.3.1 Global Animal Generic Drug Revenue by Region: 2021-2026
- 5.3.2 Global Animal Generic Drug Revenue by Region: 2027-2032
- 5.4 North America Animal Generic Drug Market Facts & Figures by Country
- 5.4.1 North America Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal Generic Drug Sales by Country (2021-2032)
- 5.4.3 North America Animal Generic Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Animal Generic Drug Market Facts & Figures by Country
- 5.5.1 Europe Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal Generic Drug Sales by Country (2021-2032)
- 5.5.3 Europe Animal Generic Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Animal Generic Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal Generic Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal Generic Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal Generic Drug Market Facts & Figures by Country
- 5.7.1 South America Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal Generic Drug Sales by Country (2021-2032)
- 5.7.3 South America Animal Generic Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Animal Generic Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal Generic Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal Generic Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Animal Generic Drug Sales by Type (2021-2032)
- 6.1.1 Global Animal Generic Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Animal Generic Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Animal Generic Drug Revenue by Type (2021-2032)
- 6.2.1 Global Animal Generic Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal Generic Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal Generic Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal Generic Drug Sales by Application (2021-2032)
- 7.1.1 Global Animal Generic Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Animal Generic Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Animal Generic Drug Revenue by Application (2021-2032)
- 7.2.1 Global Animal Generic Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal Generic Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal Generic Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal Generic Drug Value Chain Analysis
- 8.1.1 Animal Generic Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal Generic Drug Production Mode & Process
- 8.2 Animal Generic Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal Generic Drug Distributors
- 8.2.3 Animal Generic Drug Customers
9 Global Animal Generic Drug Analyzing Market Dynamics
- 9.1 Animal Generic Drug Industry Trends
- 9.2 Animal Generic Drug Industry Drivers
- 9.3 Animal Generic Drug Industry Opportunities and Challenges
- 9.4 Animal Generic Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst